Found: 15
Select item for more details and to access through your institution.
Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.866441
- By:
- Publication type:
- Article
Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 5, p. e2314393, doi. 10.1001/jamanetworkopen.2023.14393
- By:
- Publication type:
- Article
Significant healthcare burden and life cost of spinal muscular atrophy: real-world data.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 8, p. 1373, doi. 10.1007/s10198-022-01548-5
- By:
- Publication type:
- Article
Switching to Versus Addition of Incretin-Based Drugs Among Patients With Type 2 Diabetes Taking Sodium-Glucose Cotransporter-2 Inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparison of Bivalent and Monovalent mRNA Vaccine Boosters.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 633, doi. 10.1093/cid/ciad519
- By:
- Publication type:
- Article
Optimal Timing of Remdesivir Initiation in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Administered With Dexamethasone.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e499, doi. 10.1093/cid/ciab728
- By:
- Publication type:
- Article
Clinical Improvement, Outcomes, Antiviral Activity, and Costs Associated With Early Treatment With Remdesivir for Patients With Coronavirus Disease 2019 (COVID-19).
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 8, p. 1450, doi. 10.1093/cid/ciab631
- By:
- Publication type:
- Article
Risks of incident major osteoporotic fractures following SARS-CoV-2 infection among older individuals: a population-based cohort study in Hong Kong.
- Published in:
- Journal of Bone & Mineral Research, 2024, v. 39, n. 5, p. 551, doi. 10.1093/jbmr/zjae041
- By:
- Publication type:
- Article
Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID‐19: a self‐controlled case series study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 1, p. 121, doi. 10.1111/apt.16894
- By:
- Publication type:
- Article
Editorial: liver and kidney injury from remdesivir—an issue not as much as its purpose. Authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Survival after hemithyroidectomy versus total thyroidectomy in non-high-risk differentiated thyroid cancer: population-based analysis.
- Published in:
- BJS Open, 2022, v. 6, n. 6, p. 1, doi. 10.1093/bjsopen/zrac146
- By:
- Publication type:
- Article
Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43706-0
- By:
- Publication type:
- Article
Metformin Use in Relation to Clinical Outcomes and Hyperinflammatory Syndrome Among COVID-19 Patients With Type 2 Diabetes: A Propensity Score Analysis of a Territory-Wide Cohort.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.810914
- By:
- Publication type:
- Article
Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients: A Retrospective Observational Study.
- Published in:
- Pediatric Drugs, 2022, v. 24, n. 3, p. 269, doi. 10.1007/s40272-022-00500-7
- By:
- Publication type:
- Article
Effectiveness of nirmatrelvir/ritonavir in children and adolescents aged 12–17 years following SARS-CoV-2 Omicron infection: A target trial emulation.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49235-8
- By:
- Publication type:
- Article